Cite

HARVARD Citation

    Huang, H. et al. (2019). Targeting TGFβR2‐mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer. EMBO molecular medicine. 11 (11), p. n/a. [Online]. 
  
Back to record